2Lr50YtNCxgkLq7Mu6oPbFm8CvXzIL5EQI0CPRG2Dg8H6hr4l6WonXUBTn8R
Current position: Home >> Scientific Research >> Paper Publications

Controlling Conjugated Antibodies at the Molecular Level for Active Targeting Nanoparticles toward HER2-Positive Cancer Cells

Release Time:2022-11-06  Hits:

Date of Publication: 2022-10-05

Journal: MOLECULAR PHARMACEUTICS

Volume: 18

Issue: 3

Page Number: 1196-1207

ISSN: 1543-8384

Key Words: "active targeting; density; HER2; efficacy; protein corona"

Prev One:Controllable functionalization of hydroxyl-terminated self-assembled monolayers via catalytic oxa-Michael reaction

Next One:Biofunctional paper via the covalent modification of cellulose